Munich
Germany
16
2026-05-14
The entities that hold a legal rights for patent applications filed by inventor KOHLHOF Hella:
Hella KOHLHOF from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
VIDOFLUDIMUS AND RELATED STRUCTURES ACTING AS NURR1 AGONISTS
#2 | 2025-05-01CALCIUM SALT POLYMORPHS AS ANTI-INFLAMMATORY, IMMUNODULATORY AND ANTI-PROLIFERATIVE AGENTS
#3 | 2025-04-17TREATMENT OF MULTIPLE SCHLEROSIS COMPRISING DHODH INHIBITORS
#4 | 2025-01-30MEDICAL USE OF N4-HYDROXY CITICOLINE COMPOUNDS
#5 | 2024-10-10VIDOFLUDIMUS AND RELATED STRUCTURES ACTING AS NURR1 AGONISTS
#6 | 2024-06-06Treatment of Multiple Sclerosis Comprising DHODH Inhibitors
#7 | 2024-03-28Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune Diseases
#8 | 2023-04-13Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases
#9 | 2023-02-16Treatment of multiple sclerosis comprising DHODH inhibitors
#10 | 2022-10-27Vidofludimus for use in the treatment or prevention of viral diseases
#11 | 2021-10-21Vidofludimus for use in the treatment or prevention of viral diseases
#12 | 2021-03-04IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation
#13 | 2021-01-21Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents
#14 | 2020-11-19Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune Diseases
#15 | 2018-07-19Method of inhibiting DYRK1B
#16 | 2014-12-18Method of inhibiting DYRK1B
2907827 ⎘